Selected research
-
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Vaccine
-
Considerations for Cell and Gene Therapy Programs Entering the Clinical Space.
Clinical pharmacology and therapeutics
-
Population pharmacokinetic analysis of the P2X3-receptor antagonist gefapixant.
CPT: pharmacometrics & systems pharmacology